Dexamethasone Inhibits Early Regenerative Response of Rat Liver after Cold Preservation and Transplantation

Hepatology

Volumn 38, Issue 6, 2003, Pages 1563-1572

  Debonera, Fotini ^a,b   Krasinkas, Alyssa M ^a   Gelman, Andrew E ^a,b   Aldeguer, Xavier ^a   Que, Xingye ^a   Shaked, Abraham ^a,b   Olthoff, Kim M ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CYCLIN D1; DEXAMETHASONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; DRUG RESPONSE; DRUG UPTAKE; EXPERIMENTAL MODEL; INHIBITION KINETICS; LIVER CELL; LIVER GRAFT; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECIPIENT; SIGNAL TRANSDUCTION; TIME;

EID: 0142200608     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hep.2003.09.036     Document Type: Article

References (51)

1. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transpl 2001;7:835-844.
2. Deschenes M, Belle SH, Krom RAF, Zetterman RK, Lake JR. Early allograft dysfunction after liver transplantation. Transplantation 1998;66:302-310.
3. Debonera F, Aldeguer X, Shen X, Gelman AE, Gao F, Que X, Greenbaum LE, et al. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J Surg Res 2001;96:289-295.
4. Olthoff KM. Molecular pathways of regeneration and repair after liver transplantation. World J Surg 2002;26:831-837.
5. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441.
6. Cressman DE, Greenbaum LE, DeAngelis RA, Aliberto G, Furth EE, Poli V, Taub R, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379.
7. Fausto N, Laird AD, Webber EM. Role of growth factors and cytokines in hepatic regeneration. FASEB J 1995;11:1527.
8. Cressman DE, Diamond RH, Taub R. Rapid activation of the Stat3 transcription complex in liver regeneration. HEPATOLOGY 1995;21:1443.
9. Kiuchi N, Nakajima K, Ichiba M, Fukada T, Narimatsu M, Mizuno K, Hibi M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med 1999;189:63-73.
10. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994;79:551-555.
11. Jaumot M, Estanyol JM, Serratosa J, Agell N, Bachs O. Activation of cdk4 and ckd2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes. HEPATOLOGY 1999;29:385-395.
12. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
13. De Bosscher K, Schmitz Lienhard M, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. Glucocorticoid-mediated repression of nuclear factor-κ B-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A 1997;94:13504-13509.
14. Wissink S, Van Heerde EC, Van Der Burg B, Van Der Saag PT. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol Endocrinol 1998;12:355-363.
15. De Bosscher K, Vanden Berghe W, Vermeulen L, Plaisance S, Boone E, Haegeman G. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A 2000;97:3919-3924.
16. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax 2000;55:603-613.
17. Berghe VW, Francesconi E, De Bosscher K, Reche-Rigon M, Haegeman G. Dissociated glucocorticoids with anti-inflammatory potential repress IL-6 gene expression by a nuclear factor-κB-dependent mechanism. Mol Pharmacol 1999;56:797-806.
18. Michalopoulos GK, Bowen WC, Mule K, Stolz DB. Histological organization in hepatocyte organoid cultures. Am J Pathol 2001;159:1877-1887.
19. Tsukamoto I, Kojo S. Effect of glucocorticoid on liver regeneration after partial hepatectomy in the rat. Gut 1989;30:387-390.
20. Nagy P, Kiss A, Schnur J, Thorgeirsson S. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. HEPATOLOGY 1998;28:423-429.
21. Kamada N, Calne RY. Orthotopic liver transplantation in the rat: technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979;28:47-50.
22. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990;9:4477-4484.
23. Eastman-Reks SB, Vedeckis WV. Glucocorticoid inhibition of c-myc, c-myb, and c-Ki-ras expression in a mouse lymphoma cell line. Cancer Res 1986;46:2457-2462.
24. Rhee K, Bresnahan W, Hirai A, Hirai M, Thompson EA. C-myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Cancer Res 1995;55:4188-4195.
25. Gujral JS, Bucci T, Farhood A, Jaeschke H. Mechanisms of cells death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? HEPATOLOGY 2001;33:397-405.
26. Emond JC, Renz JF, Ferrell LD, Rosenthal P, Lim RC, Roberts JP, Lak JR, Ascher NL. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg 1996;224:544-552.
27. Bradham CA, Schemmer P, Stachlewitz RF, Thurman RG, Brenner DA. Activation of nuclear factor-κB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells. Liver Transpl Surg 1999;5:282-293.
28. Camargo CA Jr, Madden JF, Gao W, Selvan RS, Clavien PA. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. HEPATOLOGY 1997;26:1513-1520.
29. Que X, Debonera F, Gelman AE, Abt P, Shaked A, Olthoff KM. Intragraft IL-6 up-regulation is critical for graft survival after mouse liver transplantation. Am J Transplant 2002;2:453.
30. Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, Busuttil RW, et al. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. HEPATOLOGY 2003;37:296-303.
31. Rhee K, Reisman D, Bresnahan W, Thompson EA. Glucocorticoid regulation of G1 cyclin-dependent kinase genes in lymphoid cells. Cell Growth Differ 1995;6:691-698.
32. Reil TD, Kashyap VS, Sarkar R, Freishlag J, Gelabert HA. Dexamethasone inhibits the phosphorylation of retinoblastoma protein in the suppression of human vascular smooth muscle cell proliferation. J Surg Res 2000;92:108-113.
33. Fernandes D, Guida E, Koutsoubos V, Harris T, Vadiveloo P, Wilson JW, Stewart AG. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol 1999;21:77-88.
34. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-441.
35. Van der Saag PT, Caldenhoven E, van de StolpeA. Molecular mechanisms of steroid action: novel type of cross-tald between glucocorticoids and NF-κB transcription factors. Eur Respir J 1996;22:146S-153S.
36. Li J, Johnson TA, Hanson LA, Beer DG. Loss of glucocorticoid-dependent growth inhibition in transformed mouse lung cells. Mol Carcinog 1996;16:213-220.
37. Sikora E, Grassili E, Bellesia E, Toiano L, Franceschi C. Studies of the relationship between cell proliferation and cell death: III. AP-1 DNA binding activity during concanavalin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes. Biochem Biophys Res Commun 1993;192:386-391.
38. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995;270:23589-23597.
39. Phuchareon J, Tokuhisa T. Deregulated c-Fos/AP-1 modulates expression of the cyclin and the cdk gene in splenic B cells stimulated with lipopolysaccharide. Cancer Lett 1995;92:203-208.
40. Cato AC, Konig H, Ponta H, Herrlich P. Steroids and growth promoting factors in the regulation of expression of genes and gene networks. J Steroid Biochem Mol Biol 1992;43:63-68.
41. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148:S1-S26.
42. Campbell JS, Prichard L, Schaper F, Schmitz J, Stephenson-Famy A, Rosenfeld ME, Argast GM, et al. Expression of suppressors of cytokine signaling during liver regeneration. J Clin Invest 2001;107:1285-1292.
43. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. HEPATOLOGY 1991;13:83-95.
44. Sankary HN, Chong A, Foster P, Brown E, Shen J, Kimura R, Rayudu G, et al. Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. HEPATOLOGY 1995;22:1236-1242.
45. Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1 α, β, and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991;138:395-402.
46. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischemia/tepetfusion injury in rat liver in vivo. FASEB J 1990;4:3355-3359.
47. Poggetti RS, Moore FA, Moore EE, Bensard DD, Anderson BO, Benerjee A. Liver injury is a reversible neutrophil-mediated event following gut ischemia. Arch Surg 1992;127:175-179.
48. Teoh N, Leclercq I, Pena AD, Farrell G. Low-dose TNF-α protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. HEPATOLOGY 2003;37:118-128.
49. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. HEPATOLOGY 2000;31:149-159.
50. Pirenne J, Aerts R, Koshiba T, Gelder F, Roskams T, Schetz M, Verhaegen M, et al. Steroid-free immunosuppression during and after liver transplantation - a 3-year follow-up report. Clin Transplant 2003;17:177-182.
51. Crawford MD, Desai NM, Foreman LM, Timmons KJ, Markmann JF, Shaked A, Olthoff KM. Intra-operative steroids are not required for liver transplant immunosuppression. Am J Transplant 2002;2:198.